{"name":"Biotech Pharmaceutical Co., Ltd.","slug":"biotech-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"Nimotuzumab Injection","genericName":"Nimotuzumab Injection","slug":"nimotuzumab-injection","indication":"Head and neck squamous cell carcinoma","status":"marketed"},{"name":"nimotuzumab plus paclitaxel","genericName":"nimotuzumab plus paclitaxel","slug":"nimotuzumab-plus-paclitaxel","indication":"Non-small cell lung cancer","status":"phase_3"},{"name":"placebo plus chemoradiotherapy","genericName":"placebo plus chemoradiotherapy","slug":"placebo-plus-chemoradiotherapy","indication":"Metastatic cancer","status":"phase_3"},{"name":"placebo plus paclitaxel","genericName":"placebo plus paclitaxel","slug":"placebo-plus-paclitaxel","indication":"Breast cancer","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"painkiller","genericName":"painkiller","slug":"painkiller","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"painkiller","genericName":"painkiller","slug":"painkiller","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Nimotuzumab Injection","genericName":"Nimotuzumab Injection","slug":"nimotuzumab-injection","phase":"marketed","mechanism":"Nimotuzumab is a humanized monoclonal antibody that blocks the epidermal growth factor receptor (EGFR) to inhibit tumor cell proliferation and survival.","indications":["Head and neck squamous cell carcinoma","Non-small cell lung cancer","Nasopharyngeal carcinoma"],"catalyst":""},{"name":"nimotuzumab plus paclitaxel","genericName":"nimotuzumab plus paclitaxel","slug":"nimotuzumab-plus-paclitaxel","phase":"phase_3","mechanism":"Nimotuzumab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR), while paclitaxel is a taxane that inhibits cell division.","indications":["Non-small cell lung cancer"],"catalyst":""},{"name":"placebo plus chemoradiotherapy","genericName":"placebo plus chemoradiotherapy","slug":"placebo-plus-chemoradiotherapy","phase":"phase_3","mechanism":"This drug works by combining a placebo with chemoradiotherapy to treat cancer.","indications":["Metastatic cancer"],"catalyst":""},{"name":"placebo plus paclitaxel","genericName":"placebo plus paclitaxel","slug":"placebo-plus-paclitaxel","phase":"phase_3","mechanism":"Paclitaxel works by inhibiting cell division, thereby preventing cancer cells from growing and spreading.","indications":["Breast cancer","Ovarian cancer","Non-small cell lung cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPRnZNNXpfbkZHc2t0WjNvcmUxOWpyTFl3QWU4cm1VOFhwek5xeU41QkVwWHVHbGlPdVhUbTFVVWJxY3JpemdpUzNtVGJoRTZzdWRfWm0zeC1fM3hrckhGekFVX2tyWVJxQk00S3l6MjBSbms0RjZ6TWVWQzNiTVpXb0Q0bkZQdV9acXdfZVdCb2VXVlYzdVlJdEJWd0pJSWxNRTNZS09SMnVsN08wc3NUeHpNUGhDYjZobktSenhDcWZxQ0NG?oc=5","date":"2026-03-16","type":"pipeline","source":"AD HOC NEWS","summary":"Takeda Pharmaceutical Co Ltd stock (ISIN: JP3730800003) faces pipeline pressure amid steady core gro - AD HOC NEWS","headline":"Takeda Pharmaceutical Co Ltd stock (ISIN: JP3730800003) faces pipeline pressure amid steady core gro","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQZUc1VTZnSXYwT0hoN0ZIWm9NS3N6b1VETnRyMnB1VzRWQXQtZjdhZ29CNE5WSTRJbkhVZHVEbTZuYVZBTktqbnk5WjlqaE1rcDgyTE5CWXZKX3l5MnVxSjZBUURQUjhjcTk2ZC1Ydk96aUdaNDBfOFhVQ25LWUpWYVRFeXVFTFBVbVZfOGtTLU1PMHFnUnhBZU5Oa28zS3kwcDZmU1NNU0RDMEU?oc=5","date":"2025-11-24","type":"pipeline","source":"Quiver Quantitative","summary":"Portfolio Building Block World Pharma and Biotech Index ETF Holdings - Quiver Quantitative","headline":"Portfolio Building Block World Pharma and Biotech Index ETF Holdings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxONlFLbnNHbFZ3TkJrc2YtZ3FsRThMNW1aaHp1d1U0SVVGV09ZLWRXa1BmYVkzSks5SVVaMlAyMnROb0tFeXhLQmFoME15SFcwd1FyMzdZSHRzQXhNZGJqSGE4NDI1Q3loODl5emQzWnlMNmExcTQ1QWtYOGlzekY1d0R0VGV1THJjQTlzc2Z3V0xQMVE1d1Y3bmdrWjN2Um5OQUEzOUhZcXFGOHczVlIwVll5UkVtb2hvY2UtaFlOS3M?oc=5","date":"2025-11-17","type":"pipeline","source":"Fierce Biotech","summary":"Breaking Barriers and Crossing Borders: JCR Pharma Launches into Next 50 Years of Innovation with Global Alliances - Fierce Biotech","headline":"Breaking Barriers and Crossing Borders: JCR Pharma Launches into Next 50 Years of Innovation with Global Alliances","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AJBVV95cUxNTTJWc2xfY1NCbEJSaC1KbjlmX3JNblR6bEl4T21aV2VzS25oaWRxX25qX0FJS2hUZjVYRmtZcUEyMUt2SThXYkZvSTQ1MkwxTjVhdWUwOGRaYVJxYjc0RENyaDhudWNaU016YWU2SzRhZ3Q4NXpjaEJYYzIwMjdFOV9aY2t2c1RhcXdqdUJGR0ZMd1gtUTJzNFhSVTVfeXJHaVBmdDdsY2FORnBxaUVzVi11dzhXQW40UExNVHA3LVpQcTExMEp5aWFRUDZKNU56WFhKR3ZMM3FpbWZLM1ZrQTg3TU5XQ19aZmk5eDlQRm5CTWUzRW1SaFN2X0J4b05JalNHNFNoMmVEei0xUFU5YWxPNThSdnJsSmVsd0R3ZzNiQlAzbkRPR0Zqay1MWHdha3FUYU9NSFdFdWlyNy1SLThFMUxaVVl4dFhrdlRvTFRoUm5hZ1l1cWVQLUhsRU9sbFdiTQ?oc=5","date":"2025-11-17","type":"pipeline","source":"GlobeNewswire","summary":"$9.85 Bn Pharma And Biotech CRM Software Global Market - GlobeNewswire","headline":"$9.85 Bn Pharma And Biotech CRM Software Global Market","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-11","type":"patent","source":"The Economic Times","summary":"Cipla, Natco Pharma, Hetero Labs among Indian firms chosen to supply key generic drugs in China - The Economic Times","headline":"Cipla, Natco Pharma, Hetero Labs among Indian firms chosen to supply key generic drugs in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNWG4zbm9ZM2ZwcGNoSHU5WHFuaUJzNVM2X0JiMFRlRlVMZUNXWWJpajFFVlJURl9meEhKOXBQTDAyQXNGeGk0NEJzX0plX0dFY2pTa2JyN1EtWmxyVG1zc2lKQ2g0TEMwdlZHSGFmbGJLU3dDcUJ0U25qcFkwNFY3elVBMWhkXzlqUmhqNWJCLTY4T0ZxRFd6di1DT1BneV9RM3FHdy1mUms3eElaT0FKSUlwTWdieXFDNDM1NUNTRlpKZDZvaXNsLU4zQ3pVcjZ5RmFKYk5vOA?oc=5","date":"2025-10-14","type":"deal","source":"Reuters","summary":"US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership - Reuters","headline":"US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOVlNJQ2ttSjhmZFdtcGstdUVRaFdnVUFWbFJmeThBWF9Ma2tJR2pkTE1FV3BTNUJfZm9wOXJWd0lwMjlvbVNUSXJyS0kwS2ZOT2xrS196bUpfVDRMa2E4b0pTQmxDaUc4ek1BOUlINGpHRHgzcm9OQlFUVzhTZ3o1NmZBd3VSanBHUUtTU0NMa2MzZlZnOVVERU5oYnVKdmxIcUtscXJ5WkRtMUZHcl8wdXRNcTZvN0t6ckNMbW1R?oc=5","date":"2025-09-15","type":"deal","source":"Ocugen, Inc.","summary":"Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea - Ocugen, Inc.","headline":"Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPMlJzdE1mR2hBOUhxMFZ1RUJBcEhCUGZ3Smthd2hkRFZ0cl9UWl95N3RQQXhxemRHYlBGb2RpbHlIWm9PcWFCeGZkaTRIeHA1dlp5V1RrN3U3LUxMek1pYmhMalhuVG5tZUhXdzRXYWJLNktfYVY0UWJUWGRha043MjQxSEtwVVdxMFlzX25qTDJWSHNFeXNKTVZKeWQxZnFoQ0dj?oc=5","date":"2025-07-17","type":"pipeline","source":"BioWorld News","summary":"34 mainland China biotechs file for Hong Kong IPO in H1 2025 - BioWorld News","headline":"34 mainland China biotechs file for Hong Kong IPO in H1 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5qa2xPd3hqUW5sSV82TTZGUXJCbXRVVkMzU3VRMEtLS2JkaWhYQkxmQXAxaDA0ZlZvVzZmbjIzVW9ab01GRHNiREdFdG45R1p1S1Y4?oc=5","date":"2025-07-15","type":"pipeline","source":"FirstWord Pharma","summary":"Otsuka snaps up autoimmune antibody from Swedish biotech - FirstWord Pharma","headline":"Otsuka snaps up autoimmune antibody from Swedish biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPQm5Bb2ZDM2VWb0hRY3VGOWFSekdBV25HVUhFVk83YzBsZlQ2VHl4T1NKS1RpcjR4T2dDUl9rOXBwaTZ6dkZJSWkzUmZTZjZNVEdwRDZOWlBLU1BQdmJzSEVkb2V4emFVTGwyUFIxOEV2emwyQUN5SlBSQ01HRVBReTRwdzR1dm5oZUZQQTNFQ3dBcGJfX1ZpV2hZYlpkdFhWZG5MSm5jV1RhcS1KVUNXRExXYXQ1SkdWX2gzbi0wMDZEZTA?oc=5","date":"2025-07-13","type":"pipeline","source":"Bloomberg.com","summary":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline - Bloomberg.com","headline":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-07","type":"pipeline","source":"Medical Dialogues","summary":"Sun Pharma Advanced Research Company incorporates wholly owned subsidiary Genokine Biotech - Medical Dialogues","headline":"Sun Pharma Advanced Research Company incorporates wholly owned subsidiary Genokine Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxNaWNRWmhwVHFMaEt0amVGLWttZGZfektCQVpVaTVQcjZXMG1SZW5KT25ZYmM0ZnpYVlBlQWZUNVhsZkZpSF9BMGdBdDFwTDRxT0dGeEJWb2l1VjdmVnhSS3gtd1pCSUY2elBKeTMtOVJFU1NZbFkwdzhlWVNvbnFOTVJyNFpYcEVwY25DNWotUS1oVXpWYUp2ZTdtRW9UdERmekFmYk1XZ3pkNWVKZnc3X0JiQWRDM0FHeGRLZERjYnFWam1zaTNCOFhDYzhHbHduMF8yT2R2OEtxejEyZ05iWU5lREdJLVVjcEs2WFdkNk1MaFU?oc=5","date":"2025-06-11","type":"deal","source":"BioSpace","summary":"Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics - BioSpace","headline":"Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutic","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"marketed":2,"phase_3":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}